Cape Verde vs Myanmar: Cause of death, by non-communicable diseases, ages 5-14
Cape Verde
24.9%
in 2021
Myanmar
25.0%
in 2021
Cape Verde rank
135th
Myanmar rank
133rd
Cause of death, by non-communicable diseases, ages 5-14 over time
- Cape Verde
- Myanmar
How they compare
Myanmar currently reports 25.0% against 24.9% in Cape Verde, a difference of 0.1%.
Across all 6 years both countries report, Myanmar has been ahead every year.
Cape Verde ranks 135th and Myanmar ranks 133rd of 185 countries.
Myanmar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cape Verde | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.6% | 20.1% | 4.5% | Myanmar |
| 2010s | 23.8% | 26.4% | 2.6% | Myanmar |
| 2020s | 25.1% | 27.8% | 2.7% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Cape Verde or Myanmar?
- Myanmar, at 25.0% against 24.9% in Cape Verde as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Cape Verde and Myanmar?
- 0.1%, with Myanmar ahead.
- How many years of comparable data are there for Cape Verde and Myanmar?
- 6 years are reported by both, from 2000 to 2021.
- How do Cape Verde and Myanmar rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Cape Verde ranks 135th and Myanmar ranks 133rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.